Canavan disease (CD) is a rare leukodystrophy stemming from the loss of function in the aspartoacylase (ASPA) gene within modified ASPA-expressing mature oligodendrocytes of the central nervous system (CNS) and characterized by macrocephaly, neurodevelopmental delays, and tone abnormalities [118]. The gene discussed is ASPA; the disease is Canavan disease.